Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 3, 2009, Pages 291-298

  Tamburino, Corrado ^a   Angiolillo, Dominick J ^b   Capranzano, Piera ^a,b   Di Salvo, Marilena ^a   Ussia, Giampaolo ^a   La Manna, Alessio ^a   Guzman, Luis A ^a   Galassi, Alfredo R ^a   Bass, Theodore A ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Drug eluting stents; Left main coronary artery; Long term outcomes

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADVERSE OUTCOME; AGED; ARTICLE; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; FEASIBILITY STUDY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LEFT CORONARY ARTERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PROGNOSIS; REVASCULARIZATION; RISK FACTOR; SCORING SYSTEM; STENT THROMBOSIS; SURVIVAL RATE;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SIROLIMUS; TREATMENT OUTCOME;

EID: 65549155741     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21840     Document Type: Article

References (28)

1. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847.
2. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-175.
3. Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era - A report from the American College of Cardiology-National Cardiovascular data registry (ACC-NCDR). Catheter Cardiovasc Interv 2006;68:867-872.
4. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, Airoldi F, Michev I, Sangiorgi MG, Carlino M, Vitrella G, Colombo A. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005;111:791-795.
5. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: Comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-356.
6. Valgimigli M, van Mieghem CA, Ong ATL, Aoki J, Rodriguez Granillo GA, McFadden EP, Kappetein AP, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: Insights from the Rapamycin-Eluting and Taxus Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH and T-SEARCH) registries. Circulation 2005;111:1383-1389.
7. Sheiban I, Meliga E, Moretti C, Fumagalli A, Omedè P, Sciuto F, Grossomarra W, Trevi G. Sirolimus-eluting stents vs. bare metal stents for the treatment of unprotected left main coronary artery stenosis. Eurointervention 2006;2:356-362.
8. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, Airoldi F, Carlino M, Michev I, Melzi G, Sangiorgi G, Alfieri O, Colombo A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis. A single-center experience. Circulation 2006;113:2542-2547.
9. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870.
10. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, Bacchi-Reggiani L, Gianstefani S, Virzì S, Manara F, Kiros Weldeab M, Marinelli G, di Bartolomeo R, Branzi A. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006;98:54-59.
11. Valgimigli M, Malagutti P, Aoki J, Garcia-Garcia HM, Rodriguez Granillo GA, van Mieghem CA, Ligthart JM, Ong AT, Sianos G, Regar E, Van Domburg RT, De Feyter P, de Jaegere P, Serruys PW. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: A combined RESEARCH and T-SEARCH long-term analysis. J Am Coll Cardiol 2006;47:507-514.
12. Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, Truffa A, Montorfano M, Airoldi F, Sangiorgi G, Carlino M, Michev I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Rogacka R, Serruys PW, Colombo A. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: A multicenter registry. Circulation 2007;116:158-162.
13. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008;51:538-545.
14. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Stents versus coronary-artery bypass grafting for the left main coronary artery disease. N Engl J Med 2008;358:1781-1792.
15. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease the DELFT (drug eluting stent for LeFT main) registry. J Am Coll Cardiol 2008;51:2212-2219.
16. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroScore). Eur J Cardiothorac Surg 1999;16:9-13.
17. Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP, Tamburino C. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "Mini-Crush Technique." Catheter Cardiovasc Interv 2007;69:976-983.
18. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, on behalf of the Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
19. Laskey WK, Yancy CW, Maisel WK. Thrombosis in coronary drug-eluting stents: Report from the Meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006. Circulation 2007;115:2352-2357.
20. Serruys PW. The synergy between percutaneous coronary intervention with TAXUS and cardiac surgery: The SYNTAX Study. Presented at the Late Breaking Clinical Trials at the European Society of Cardiology Congress, Munich, Germany, August 30 - September 3, 2008.
21. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS; EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007;297:2001-2009.
22. Sheiban I, Meliga E, Moretti C, Biondi-Zoccai G, Rosano G, Sciuto F, Marra WG, Omedè P, Gerasimou A, Trevi GP. Long-term clinical and angiographic outcomes of treatment of unprotected left main artery stenosis with Sirolimus-eluting stent. Am J Cardiol 2007;100:431-435.
23. Kim YH, Ahn JM, Park DW, Lee BK, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. EuroScore as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol 2006;98:1567-1570.
24. Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Carcia HM, Polad J, Tsuchida K, Regar E, van der Giessen WJ, Jaegere P, De Feyter P, Serruys PW. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: An integrated clinical and angiographic analysis based on the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-stent evaluated at Rotterdam Cardiology Hospital (TSEARCH) Registries. J Am Coll Cardiol 2006;47:1530-1537.
25. Valgimigli M, Malagutti P, Rodriguez Granillo GA, Tsuchida K, Garcia-Garcia HM, van Mieghem CA, Van der Giessen WJ, De Feyter P, de Jaegere P, Van Domburg RT, Serruys PW. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J 2006;152:896-902.
26. Colombo A, Stankovic G, Orlic D, Corvaja N, Liistro F, Airoldi F, Chieffo A, Spanos V, Montorfano M, Di Mario C. Modified T-stenting technique with crushing for bifurcation lesions: Immediate results and 30-day outcome. Catheter Cardiovasc Interv 2003;60:145-151.
27. Kim YH, Park SW, Hong MK, Park DW, Park KM, Lee BK, Song JM, Han KH, Lee CW, Kang DH, Song JK, Kim JJ, Park SJ. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006;97:1597-1601.
28. Hoye A, Jakovou J, Ge L, van Mieghem CA, Ong ATL, Cosgrave J, Sangiorgi GM, Airoldi F, Montorfano M, Michev I, Chieffo A, Carlino M, Corvaja N, Aoli J, Rodriguez Granillo GA, Valgimigli M, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW, Colombo A. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique. J Am Coll Cardiol 2006;47:1949-1958.